NCT03454152

Brief Summary

Diabetic ketoacidosis (DKA) is an important complication of childhood diabetes mellitus and the most frequent diabetes-related cause of death in children. Diabetic ketoacidosis (DKA) is caused by a decrease in effective circulating insulin associated with increases in counter regulatory hormones including glucagon, catecholamines, cortisol, and growth hormone. This leads to increased glucose production by the liver and kidney and impaired peripheral glucose utilisation with resultant hyperglycaemia, and hyperosmolality. Increased lipolysis, with ketone body (beta-hydroxybutyrate, acetoacetate) production causes ketonaemia and metabolic acidosis. Hyperglycaemia and acidosis result in osmotic diuresis, dehydration, and obligate loss of electrolytes.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2019

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 5, 2018

Completed
12 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

March 5, 2018

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

February 18, 2018

Last Update Submit

March 2, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Echocardiography parameters

    Right and left ventricular dimension during diabetic ketoacidosis and after correction.

    baseline

  • Electrocardiogram parameters

    QT interval and PR interval.

    baseline

Secondary Outcomes (2)

  • Electrocardiogram changes

    baseline

  • Echocardiography findings

    baseline

Study Arms (1)

patients

pediatric patients with diabetic ketoacidosis come to Assuit University Children Hospital within one year. Electrocardiogram and echocardiography will be done to all patient with diabetic ketoacidosis

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

All pediatric patients with diabetic ketoacidosis come to Assuit University Children Hospital within one year.

You may qualify if:

  • Pediatric patients aged : 1 month -18years with diabetic ketoacidosis

You may not qualify if:

  • Pediatric Patients who have associated cardiovascular disease. ( congenital or rheumatic).
  • Pediatric patients with hyperglycemic hyperosmolar state.
  • Pediatric patients with other causes of metabolic acidosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child. 1999 Oct;81(4):318-23. doi: 10.1136/adc.81.4.318.

    PMID: 10490436BACKGROUND
  • Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI; ESPE; LWPES. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004 Feb;89(2):188-94. doi: 10.1136/adc.2003.044875.

    PMID: 14736641BACKGROUND
  • Gandhi MJ, Suvarna TT. Cardiovascular complications in diabetic ketoacidosis. Int J Diab Dev Countries. 1995;15:132-133.

    BACKGROUND
  • Chung EK. Electrolyte imbalance and cardiac arrhythmias. In : Principles of Cardiac Arrhythmias. Edward Chung (ed.) Williams and Wilkins, 1989.

    BACKGROUND

Central Study Contacts

Hanaa Mohammad, prof

CONTACT

Hekma Farghaly, Dr

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 18, 2018

First Posted

March 5, 2018

Study Start

March 1, 2019

Primary Completion

March 1, 2020

Study Completion

June 1, 2020

Last Updated

March 5, 2018

Record last verified: 2018-03